2018 Regular Session ENROLLED
SENATE BILL NO. 28
BY SENATOR MILLS
1 AN ACT
2 To enact R.S. 37:1251(D) and R.S. 40:978(F)(3) and 978.3(E), relative to veterinarians; to
3 exempt veterinarians and certain manufacturers from disclosure of prescription drug
4 price information provisions; to exempt veterinarians from accessing the prescription
5 monitoring program prior to prescribing an opioid; to exempt veterinarians from
6 continuing education requirements for prescribers of controlled dangerous
7 substances; and to provide for related matters.
8 Be it enacted by the Legislature of Louisiana:
9 Section 1. R.S. 37:1251(D) is hereby enacted to read as follows:
10 §1251. Disclosure of prescription drug price information
11 * * *
12 D. The provisions of this Section shall not apply to veterinarians or
13 pharmaceutical marketers who engage in any form of prescription drug
14 marketing directly to a prescriber, his designee, or any member of his staff
15 regarding prescription drugs manufactured exclusively for nonhuman
16 consumption.
17 Section 2. R.S. 40:978(F)(3) and 978.3(E) are hereby enacted to read as follows:
18 §978. Prescriptions
19 * * *
20 F.
21 * * *
22 (3) The provisions of this Subsection shall not apply to individuals
23 licensed by the Louisiana Board of Veterinary Medicine.
24 * * *
ACT No. 219
Page 1 of 2
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 28 ENROLLED
1 §978.3. Continuing education for the prescribing of controlled substances
2 * * *
3 E. The provisions of this Section shall not apply to individuals licensed
4 by the Louisiana Board of Veterinary Medicine.
PRESIDENT OF THE SENATE
SPEAKER OF THE HOUSE OF REPRESENTATIVES
GOVERNOR OF THE STATE OF LOUISIANA
APPROVED:
Page 2 of 2
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions.